Analysis of centrally acting muscle relaxants marketed in Brazil from the perspective of Elderly Care
DOI:
https://doi.org/10.22421/15177130-2017v18n1p108Keywords:
Muscle Relaxants, Centrally acting, Elderly Health. Medicine Package Inserts, Product Surveillance, Postmarketing.Abstract
Objective: To analyze the scientific evidence regarding the therapeutic use and safety of muscle relaxant medicines registered in Brazil from the perspective of the health of the elderly.Methods: This is a study of the analysis of the supply of medicines containing group M03B drugs – Centrally acting muscle relaxants of the Anatomical Therapeutic Chemical classification. The M03B group drugs registered in Brazil were observed. The scientific evidence on safety and efficacy has been investigated. The availability of safety information in the package leaflet was analyzed.
Results: We identified 18 drugs from group M03B, of which 7 (38.9%) are registered in Brazil. Of the 67 specialties registered, 35 (52.2%) are pharmacological associations.
Conclusion: Evidence for the use of musclerelaxants in the elderly is limited. The package leaflets do not contain relevant information on adverse events.
Downloads
Published
2017-07-17
How to Cite
1.
Carmo Júnior NM do, Reis AMM. Analysis of centrally acting muscle relaxants marketed in Brazil from the perspective of Elderly Care. Espac. Saude [Internet]. 2017 Jul. 17 [cited 2024 Dec. 4];18(1):108-16. Available from: https://espacoparasaude.fpp.edu.br/index.php/espacosaude/article/view/351
Issue
Section
Artigos
License
Copyright (c) 2017 Espaço para a Saúde
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in this journal agree to the following terms:
- Authors grant the journal the copyright, with the work simultaneously licensed with Creative Commons CC BY, which allows the sharing of work with recognition of authorship and initial publication in this journal.
- Authors are authorized to assume additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (e.g., to publish in an institutional repository or as a book chapter), with authorship recognition and initial publication in this journal.
- Authors are permitted and encouraged to publish and distribute their work online (e.g., in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes, as well as increase the impact and the citation of the published work (See The Effect of Free Access).